Objectives

After participating in this educational activity, attendees should be able to:
1. Review GLP-1 receptor agonists background and place in therapy for treatment of Type 2 diabetes
2. Discuss primary literature regarding efficacy and safety of oral semaglutide in patients with Type 2 diabetes
3. Identify which patients may be appropriate candiates for oral GLP-1RA therapy.

Faculty

Kelsey Leite, PharmD 
PGY1 Community-Based Pharmacy Resident
Pharmacist
Baystate Medical Center 

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.